nodes	percent_of_prediction	percent_of_DWPC	metapath
Salmeterol—CYP3A5—Disulfiram—alcohol dependence	0.282	0.6	CbGbCtD
Salmeterol—CYP3A4—Disulfiram—alcohol dependence	0.11	0.234	CbGbCtD
Salmeterol—CYP3A4—Citalopram—alcohol dependence	0.0783	0.167	CbGbCtD
Salmeterol—Hyperkinesia—Acamprosate—alcohol dependence	0.00188	0.00481	CcSEcCtD
Salmeterol—Heartburn—Citalopram—alcohol dependence	0.00188	0.0048	CcSEcCtD
Salmeterol—Laryngitis—Citalopram—alcohol dependence	0.00179	0.00458	CcSEcCtD
Salmeterol—Hyperkinesia—Naltrexone—alcohol dependence	0.00178	0.00455	CcSEcCtD
Salmeterol—Gastroenteritis—Acamprosate—alcohol dependence	0.00176	0.00451	CcSEcCtD
Salmeterol—Dermatitis atopic—Citalopram—alcohol dependence	0.00175	0.00446	CcSEcCtD
Salmeterol—Eczema—Acamprosate—alcohol dependence	0.00174	0.00445	CcSEcCtD
Salmeterol—Glaucoma—Citalopram—alcohol dependence	0.00172	0.00439	CcSEcCtD
Salmeterol—Sleep disorder—Naltrexone—alcohol dependence	0.00171	0.00437	CcSEcCtD
Salmeterol—Injury—Acamprosate—alcohol dependence	0.0017	0.00435	CcSEcCtD
Salmeterol—Swelling—Naltrexone—alcohol dependence	0.00168	0.00429	CcSEcCtD
Salmeterol—Gastroenteritis—Naltrexone—alcohol dependence	0.00167	0.00427	CcSEcCtD
Salmeterol—Nasal congestion—Naltrexone—alcohol dependence	0.00162	0.00416	CcSEcCtD
Salmeterol—Rhinorrhoea—Citalopram—alcohol dependence	0.00159	0.00408	CcSEcCtD
Salmeterol—Dysphonia—Citalopram—alcohol dependence	0.00157	0.00402	CcSEcCtD
Salmeterol—Atrial fibrillation—Naltrexone—alcohol dependence	0.00156	0.00399	CcSEcCtD
Salmeterol—Pallor—Citalopram—alcohol dependence	0.00156	0.00399	CcSEcCtD
Salmeterol—Endocrine disorder—Citalopram—alcohol dependence	0.00156	0.00399	CcSEcCtD
Salmeterol—Migraine—Acamprosate—alcohol dependence	0.00154	0.00394	CcSEcCtD
Salmeterol—Extrasystoles—Citalopram—alcohol dependence	0.00154	0.00393	CcSEcCtD
Salmeterol—Contusion—Citalopram—alcohol dependence	0.00148	0.00379	CcSEcCtD
Salmeterol—Pain in extremity—Naltrexone—alcohol dependence	0.00148	0.00379	CcSEcCtD
Salmeterol—Chest discomfort—Citalopram—alcohol dependence	0.00146	0.00373	CcSEcCtD
Salmeterol—Migraine—Naltrexone—alcohol dependence	0.00146	0.00373	CcSEcCtD
Salmeterol—Musculoskeletal stiffness—Citalopram—alcohol dependence	0.00144	0.00368	CcSEcCtD
Salmeterol—Viral infection—Citalopram—alcohol dependence	0.00143	0.00366	CcSEcCtD
Salmeterol—Dysmenorrhoea—Citalopram—alcohol dependence	0.00142	0.00363	CcSEcCtD
Salmeterol—Irritability—Naltrexone—alcohol dependence	0.00141	0.00361	CcSEcCtD
Salmeterol—Paraesthesia—Disulfiram—alcohol dependence	0.0014	0.00358	CcSEcCtD
Salmeterol—Cataract—Citalopram—alcohol dependence	0.00136	0.00347	CcSEcCtD
Salmeterol—Asthma—Acamprosate—alcohol dependence	0.00135	0.00346	CcSEcCtD
Salmeterol—Influenza—Acamprosate—alcohol dependence	0.00135	0.00346	CcSEcCtD
Salmeterol—Abdominal pain upper—Naltrexone—alcohol dependence	0.00135	0.00346	CcSEcCtD
Salmeterol—Bone pain—Citalopram—alcohol dependence	0.00135	0.00345	CcSEcCtD
Salmeterol—Fatigue—Disulfiram—alcohol dependence	0.00135	0.00344	CcSEcCtD
Salmeterol—Pain—Disulfiram—alcohol dependence	0.00133	0.00341	CcSEcCtD
Salmeterol—Cramp muscle—Naltrexone—alcohol dependence	0.00133	0.00341	CcSEcCtD
Salmeterol—Nasopharyngitis—Naltrexone—alcohol dependence	0.00132	0.00339	CcSEcCtD
Salmeterol—Neck pain—Citalopram—alcohol dependence	0.00131	0.00334	CcSEcCtD
Salmeterol—Musculoskeletal pain—Citalopram—alcohol dependence	0.00131	0.00334	CcSEcCtD
Salmeterol—Bronchitis—Acamprosate—alcohol dependence	0.0013	0.00333	CcSEcCtD
Salmeterol—Ventricular tachycardia—Citalopram—alcohol dependence	0.00129	0.0033	CcSEcCtD
Salmeterol—Influenza—Naltrexone—alcohol dependence	0.00128	0.00327	CcSEcCtD
Salmeterol—Dermatitis contact—Citalopram—alcohol dependence	0.00128	0.00327	CcSEcCtD
Salmeterol—Candida infection—Citalopram—alcohol dependence	0.00123	0.00315	CcSEcCtD
Salmeterol—Bronchitis—Naltrexone—alcohol dependence	0.00123	0.00315	CcSEcCtD
Salmeterol—Abdominal discomfort—Naltrexone—alcohol dependence	0.00123	0.00314	CcSEcCtD
Salmeterol—Hyperglycaemia—Acamprosate—alcohol dependence	0.00122	0.00312	CcSEcCtD
Salmeterol—Pneumonia—Acamprosate—alcohol dependence	0.00121	0.0031	CcSEcCtD
Salmeterol—Upper respiratory tract infection—Naltrexone—alcohol dependence	0.00119	0.00304	CcSEcCtD
Salmeterol—Cramps of lower extremities—Citalopram—alcohol dependence	0.00119	0.00304	CcSEcCtD
Salmeterol—Urinary tract infection—Acamprosate—alcohol dependence	0.00117	0.003	CcSEcCtD
Salmeterol—Pneumonia—Naltrexone—alcohol dependence	0.00115	0.00293	CcSEcCtD
Salmeterol—Infestation NOS—Naltrexone—alcohol dependence	0.00114	0.00292	CcSEcCtD
Salmeterol—Infestation—Naltrexone—alcohol dependence	0.00114	0.00292	CcSEcCtD
Salmeterol—Epistaxis—Acamprosate—alcohol dependence	0.00114	0.00291	CcSEcCtD
Salmeterol—Hyperkinesia—Citalopram—alcohol dependence	0.00113	0.00288	CcSEcCtD
Salmeterol—Asthenia—Disulfiram—alcohol dependence	0.00112	0.00286	CcSEcCtD
Salmeterol—Urinary tract infection—Naltrexone—alcohol dependence	0.00111	0.00284	CcSEcCtD
Salmeterol—Conjunctivitis—Naltrexone—alcohol dependence	0.00111	0.00284	CcSEcCtD
Salmeterol—Ear pain—Citalopram—alcohol dependence	0.0011	0.00281	CcSEcCtD
Salmeterol—Rhinitis—Acamprosate—alcohol dependence	0.00108	0.00277	CcSEcCtD
Salmeterol—Sleep disorder—Citalopram—alcohol dependence	0.00108	0.00277	CcSEcCtD
Salmeterol—Epistaxis—Naltrexone—alcohol dependence	0.00108	0.00275	CcSEcCtD
Salmeterol—Pharyngitis—Acamprosate—alcohol dependence	0.00107	0.00275	CcSEcCtD
Salmeterol—Sinusitis—Naltrexone—alcohol dependence	0.00107	0.00274	CcSEcCtD
Salmeterol—Gastroenteritis—Citalopram—alcohol dependence	0.00106	0.00271	CcSEcCtD
Salmeterol—Eczema—Citalopram—alcohol dependence	0.00104	0.00267	CcSEcCtD
Salmeterol—Dizziness—Disulfiram—alcohol dependence	0.00103	0.00264	CcSEcCtD
Salmeterol—Nasal congestion—Citalopram—alcohol dependence	0.00103	0.00263	CcSEcCtD
Salmeterol—Injury—Citalopram—alcohol dependence	0.00102	0.00261	CcSEcCtD
Salmeterol—Pharyngitis—Naltrexone—alcohol dependence	0.00102	0.0026	CcSEcCtD
Salmeterol—Connective tissue disorder—Naltrexone—alcohol dependence	0.00101	0.00257	CcSEcCtD
Salmeterol—Atrial fibrillation—Citalopram—alcohol dependence	0.00099	0.00253	CcSEcCtD
Salmeterol—Rash—Disulfiram—alcohol dependence	0.000984	0.00252	CcSEcCtD
Salmeterol—Headache—Disulfiram—alcohol dependence	0.000978	0.0025	CcSEcCtD
Salmeterol—Immune system disorder—Acamprosate—alcohol dependence	0.000977	0.0025	CcSEcCtD
Salmeterol—Cardiac disorder—Naltrexone—alcohol dependence	0.00095	0.00243	CcSEcCtD
Salmeterol—Mental disorder—Acamprosate—alcohol dependence	0.000948	0.00242	CcSEcCtD
Salmeterol—Malnutrition—Acamprosate—alcohol dependence	0.000942	0.00241	CcSEcCtD
Salmeterol—Pain in extremity—Citalopram—alcohol dependence	0.000938	0.0024	CcSEcCtD
Salmeterol—Immune system disorder—Naltrexone—alcohol dependence	0.000925	0.00237	CcSEcCtD
Salmeterol—Tension—Acamprosate—alcohol dependence	0.000924	0.00236	CcSEcCtD
Salmeterol—Migraine—Citalopram—alcohol dependence	0.000923	0.00236	CcSEcCtD
Salmeterol—Mediastinal disorder—Naltrexone—alcohol dependence	0.000923	0.00236	CcSEcCtD
Salmeterol—Nervousness—Acamprosate—alcohol dependence	0.000915	0.00234	CcSEcCtD
Salmeterol—Back pain—Acamprosate—alcohol dependence	0.000911	0.00233	CcSEcCtD
Salmeterol—Muscle spasms—Acamprosate—alcohol dependence	0.000906	0.00232	CcSEcCtD
Salmeterol—Mental disorder—Naltrexone—alcohol dependence	0.000897	0.00229	CcSEcCtD
Salmeterol—Irritability—Citalopram—alcohol dependence	0.000895	0.00229	CcSEcCtD
Salmeterol—Malnutrition—Naltrexone—alcohol dependence	0.000891	0.00228	CcSEcCtD
Salmeterol—Tremor—Acamprosate—alcohol dependence	0.000883	0.00226	CcSEcCtD
Salmeterol—Tension—Naltrexone—alcohol dependence	0.000875	0.00224	CcSEcCtD
Salmeterol—Ill-defined disorder—Acamprosate—alcohol dependence	0.000874	0.00224	CcSEcCtD
Salmeterol—Agitation—Acamprosate—alcohol dependence	0.000866	0.00221	CcSEcCtD
Salmeterol—Nervousness—Naltrexone—alcohol dependence	0.000866	0.00221	CcSEcCtD
Salmeterol—Back pain—Naltrexone—alcohol dependence	0.000862	0.00221	CcSEcCtD
Salmeterol—Angioedema—Acamprosate—alcohol dependence	0.000861	0.0022	CcSEcCtD
Salmeterol—Muscle spasms—Naltrexone—alcohol dependence	0.000857	0.00219	CcSEcCtD
Salmeterol—Abdominal pain upper—Citalopram—alcohol dependence	0.000856	0.00219	CcSEcCtD
Salmeterol—Malaise—Acamprosate—alcohol dependence	0.00085	0.00217	CcSEcCtD
Salmeterol—Cramp muscle—Citalopram—alcohol dependence	0.000844	0.00216	CcSEcCtD
Salmeterol—Nasopharyngitis—Citalopram—alcohol dependence	0.000839	0.00214	CcSEcCtD
Salmeterol—Tremor—Naltrexone—alcohol dependence	0.000835	0.00214	CcSEcCtD
Salmeterol—Palpitations—Acamprosate—alcohol dependence	0.000832	0.00213	CcSEcCtD
Salmeterol—Ill-defined disorder—Naltrexone—alcohol dependence	0.000827	0.00212	CcSEcCtD
Salmeterol—Cough—Acamprosate—alcohol dependence	0.000822	0.0021	CcSEcCtD
Salmeterol—Agitation—Naltrexone—alcohol dependence	0.000819	0.00209	CcSEcCtD
Salmeterol—Angioedema—Naltrexone—alcohol dependence	0.000814	0.00208	CcSEcCtD
Salmeterol—Hypertension—Acamprosate—alcohol dependence	0.000813	0.00208	CcSEcCtD
Salmeterol—Influenza—Citalopram—alcohol dependence	0.00081	0.00207	CcSEcCtD
Salmeterol—Asthma—Citalopram—alcohol dependence	0.00081	0.00207	CcSEcCtD
Salmeterol—Malaise—Naltrexone—alcohol dependence	0.000804	0.00206	CcSEcCtD
Salmeterol—Arthralgia—Acamprosate—alcohol dependence	0.000802	0.00205	CcSEcCtD
Salmeterol—Chest pain—Acamprosate—alcohol dependence	0.000802	0.00205	CcSEcCtD
Salmeterol—Myalgia—Acamprosate—alcohol dependence	0.000802	0.00205	CcSEcCtD
Salmeterol—Anxiety—Acamprosate—alcohol dependence	0.000799	0.00204	CcSEcCtD
Salmeterol—Bronchospasm—Citalopram—alcohol dependence	0.000797	0.00204	CcSEcCtD
Salmeterol—Unspecified disorder of skin and subcutaneous tissue—Acamprosate—alcohol dependence	0.000796	0.00204	CcSEcCtD
Salmeterol—Discomfort—Acamprosate—alcohol dependence	0.000792	0.00203	CcSEcCtD
Salmeterol—Palpitations—Naltrexone—alcohol dependence	0.000788	0.00201	CcSEcCtD
Salmeterol—Dry mouth—Acamprosate—alcohol dependence	0.000784	0.00201	CcSEcCtD
Salmeterol—Bronchitis—Citalopram—alcohol dependence	0.000779	0.00199	CcSEcCtD
Salmeterol—Cough—Naltrexone—alcohol dependence	0.000778	0.00199	CcSEcCtD
Salmeterol—Abdominal discomfort—Citalopram—alcohol dependence	0.000777	0.00199	CcSEcCtD
Salmeterol—Hypertension—Naltrexone—alcohol dependence	0.000769	0.00197	CcSEcCtD
Salmeterol—Anaphylactic shock—Acamprosate—alcohol dependence	0.000769	0.00197	CcSEcCtD
Salmeterol—Infection—Acamprosate—alcohol dependence	0.000764	0.00195	CcSEcCtD
Salmeterol—Chest pain—Naltrexone—alcohol dependence	0.000759	0.00194	CcSEcCtD
Salmeterol—Arthralgia—Naltrexone—alcohol dependence	0.000759	0.00194	CcSEcCtD
Salmeterol—Myalgia—Naltrexone—alcohol dependence	0.000759	0.00194	CcSEcCtD
Salmeterol—Anxiety—Naltrexone—alcohol dependence	0.000756	0.00193	CcSEcCtD
Salmeterol—Unspecified disorder of skin and subcutaneous tissue—Naltrexone—alcohol dependence	0.000754	0.00193	CcSEcCtD
Salmeterol—Upper respiratory tract infection—Citalopram—alcohol dependence	0.000753	0.00193	CcSEcCtD
Salmeterol—Tachycardia—Acamprosate—alcohol dependence	0.00075	0.00192	CcSEcCtD
Salmeterol—Discomfort—Naltrexone—alcohol dependence	0.00075	0.00192	CcSEcCtD
Salmeterol—Skin disorder—Acamprosate—alcohol dependence	0.000747	0.00191	CcSEcCtD
Salmeterol—Dry mouth—Naltrexone—alcohol dependence	0.000742	0.0019	CcSEcCtD
Salmeterol—CYP3A7—Biological oxidations—ADH7—alcohol dependence	0.000741	0.00534	CbGpPWpGaD
Salmeterol—CYP3A5—Biological oxidations—ADH1A—alcohol dependence	0.000741	0.00534	CbGpPWpGaD
Salmeterol—CYP3A5—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000733	0.00528	CbGpPWpGaD
Salmeterol—Hyperglycaemia—Citalopram—alcohol dependence	0.000731	0.00187	CcSEcCtD
Salmeterol—Anaphylactic shock—Naltrexone—alcohol dependence	0.000727	0.00186	CcSEcCtD
Salmeterol—Oedema—Naltrexone—alcohol dependence	0.000727	0.00186	CcSEcCtD
Salmeterol—Pneumonia—Citalopram—alcohol dependence	0.000727	0.00186	CcSEcCtD
Salmeterol—Infection—Naltrexone—alcohol dependence	0.000723	0.00185	CcSEcCtD
Salmeterol—Infestation NOS—Citalopram—alcohol dependence	0.000723	0.00185	CcSEcCtD
Salmeterol—Infestation—Citalopram—alcohol dependence	0.000723	0.00185	CcSEcCtD
Salmeterol—Nervous system disorder—Naltrexone—alcohol dependence	0.000713	0.00182	CcSEcCtD
Salmeterol—CYP3A7—Biological oxidations—GGT2—alcohol dependence	0.00071	0.00512	CbGpPWpGaD
Salmeterol—Tachycardia—Naltrexone—alcohol dependence	0.00071	0.00182	CcSEcCtD
Salmeterol—Skin disorder—Naltrexone—alcohol dependence	0.000707	0.00181	CcSEcCtD
Salmeterol—Conjunctivitis—Citalopram—alcohol dependence	0.000702	0.0018	CcSEcCtD
Salmeterol—Urinary tract infection—Citalopram—alcohol dependence	0.000702	0.0018	CcSEcCtD
Salmeterol—Musculoskeletal discomfort—Acamprosate—alcohol dependence	0.0007	0.00179	CcSEcCtD
Salmeterol—ADRB2—GPCRs, Class A Rhodopsin-like—OPRK1—alcohol dependence	0.000696	0.00501	CbGpPWpGaD
Salmeterol—Insomnia—Acamprosate—alcohol dependence	0.000695	0.00178	CcSEcCtD
Salmeterol—Paraesthesia—Acamprosate—alcohol dependence	0.00069	0.00177	CcSEcCtD
Salmeterol—CYP3A7—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000689	0.00497	CbGpPWpGaD
Salmeterol—CYP3A4—Xenobiotics—CYP2E1—alcohol dependence	0.000688	0.00496	CbGpPWpGaD
Salmeterol—Dyspnoea—Acamprosate—alcohol dependence	0.000685	0.00175	CcSEcCtD
Salmeterol—Epistaxis—Citalopram—alcohol dependence	0.000682	0.00174	CcSEcCtD
Salmeterol—Sinusitis—Citalopram—alcohol dependence	0.000678	0.00173	CcSEcCtD
Salmeterol—Dyspepsia—Acamprosate—alcohol dependence	0.000677	0.00173	CcSEcCtD
Salmeterol—Musculoskeletal discomfort—Naltrexone—alcohol dependence	0.000663	0.0017	CcSEcCtD
Salmeterol—CYP3A4—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.000661	0.00477	CbGpPWpGaD
Salmeterol—CYP3A4—Aflatoxin activation and detoxification—GGT1—alcohol dependence	0.000658	0.00474	CbGpPWpGaD
Salmeterol—Insomnia—Naltrexone—alcohol dependence	0.000658	0.00168	CcSEcCtD
Salmeterol—Pain—Acamprosate—alcohol dependence	0.000657	0.00168	CcSEcCtD
Salmeterol—Constipation—Acamprosate—alcohol dependence	0.000657	0.00168	CcSEcCtD
Salmeterol—Paraesthesia—Naltrexone—alcohol dependence	0.000653	0.00167	CcSEcCtD
Salmeterol—Rhinitis—Citalopram—alcohol dependence	0.00065	0.00166	CcSEcCtD
Salmeterol—CYP3A7—Biological oxidations—ADH1B—alcohol dependence	0.00065	0.00468	CbGpPWpGaD
Salmeterol—Dyspnoea—Naltrexone—alcohol dependence	0.000649	0.00166	CcSEcCtD
Salmeterol—CYP3A4—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.000648	0.00467	CbGpPWpGaD
Salmeterol—Pharyngitis—Citalopram—alcohol dependence	0.000644	0.00165	CcSEcCtD
Salmeterol—ADRB2—GPCRs, Other—DRD4—alcohol dependence	0.000643	0.00463	CbGpPWpGaD
Salmeterol—CYP2C8—Biological oxidations—ADH1A—alcohol dependence	0.000642	0.00463	CbGpPWpGaD
Salmeterol—Connective tissue disorder—Citalopram—alcohol dependence	0.000637	0.00163	CcSEcCtD
Salmeterol—CYP2C8—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000635	0.00457	CbGpPWpGaD
Salmeterol—Feeling abnormal—Acamprosate—alcohol dependence	0.000634	0.00162	CcSEcCtD
Salmeterol—CYP3A5—Biological oxidations—ADH4—alcohol dependence	0.00063	0.00454	CbGpPWpGaD
Salmeterol—Gastrointestinal pain—Acamprosate—alcohol dependence	0.000629	0.00161	CcSEcCtD
Salmeterol—Fatigue—Naltrexone—alcohol dependence	0.000627	0.0016	CcSEcCtD
Salmeterol—CYP3A5—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000623	0.00449	CbGpPWpGaD
Salmeterol—Constipation—Naltrexone—alcohol dependence	0.000622	0.00159	CcSEcCtD
Salmeterol—Pain—Naltrexone—alcohol dependence	0.000622	0.00159	CcSEcCtD
Salmeterol—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000614	0.00443	CbGpPWpGaD
Salmeterol—ADRB2—GPCRs, Other—CNR1—alcohol dependence	0.000614	0.00442	CbGpPWpGaD
Salmeterol—Urticaria—Acamprosate—alcohol dependence	0.000611	0.00156	CcSEcCtD
Salmeterol—ADRB2—Calcium Regulation in the Cardiac Cell—CHRM2—alcohol dependence	0.000608	0.00438	CbGpPWpGaD
Salmeterol—Abdominal pain—Acamprosate—alcohol dependence	0.000608	0.00155	CcSEcCtD
Salmeterol—Body temperature increased—Acamprosate—alcohol dependence	0.000608	0.00155	CcSEcCtD
Salmeterol—CYP3A5—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000606	0.00437	CbGpPWpGaD
Salmeterol—Cardiac disorder—Citalopram—alcohol dependence	0.000602	0.00154	CcSEcCtD
Salmeterol—Feeling abnormal—Naltrexone—alcohol dependence	0.000599	0.00153	CcSEcCtD
Salmeterol—ADRB2—GPCRs, Other—HTR7—alcohol dependence	0.000599	0.00432	CbGpPWpGaD
Salmeterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—OPRK1—alcohol dependence	0.000596	0.0043	CbGpPWpGaD
Salmeterol—Gastrointestinal pain—Naltrexone—alcohol dependence	0.000595	0.00152	CcSEcCtD
Salmeterol—Immune system disorder—Citalopram—alcohol dependence	0.000586	0.0015	CcSEcCtD
Salmeterol—Mediastinal disorder—Citalopram—alcohol dependence	0.000585	0.0015	CcSEcCtD
Salmeterol—Arrhythmia—Citalopram—alcohol dependence	0.00058	0.00148	CcSEcCtD
Salmeterol—Urticaria—Naltrexone—alcohol dependence	0.000578	0.00148	CcSEcCtD
Salmeterol—Abdominal pain—Naltrexone—alcohol dependence	0.000575	0.00147	CcSEcCtD
Salmeterol—Body temperature increased—Naltrexone—alcohol dependence	0.000575	0.00147	CcSEcCtD
Salmeterol—ADRB2—G alpha (s) signalling events—CRH—alcohol dependence	0.000574	0.00414	CbGpPWpGaD
Salmeterol—Mental disorder—Citalopram—alcohol dependence	0.000568	0.00145	CcSEcCtD
Salmeterol—CYP3A7—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000567	0.00409	CbGpPWpGaD
Salmeterol—Hypersensitivity—Acamprosate—alcohol dependence	0.000566	0.00145	CcSEcCtD
Salmeterol—CYP2C8—Arachidonic acid metabolism—GGT1—alcohol dependence	0.000565	0.00407	CbGpPWpGaD
Salmeterol—Malnutrition—Citalopram—alcohol dependence	0.000565	0.00144	CcSEcCtD
Salmeterol—Tension—Citalopram—alcohol dependence	0.000554	0.00142	CcSEcCtD
Salmeterol—Asthenia—Acamprosate—alcohol dependence	0.000552	0.00141	CcSEcCtD
Salmeterol—CYP3A4—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.000551	0.00397	CbGpPWpGaD
Salmeterol—Nervousness—Citalopram—alcohol dependence	0.000548	0.0014	CcSEcCtD
Salmeterol—Back pain—Citalopram—alcohol dependence	0.000546	0.0014	CcSEcCtD
Salmeterol—CYP2C8—Biological oxidations—ADH4—alcohol dependence	0.000546	0.00393	CbGpPWpGaD
Salmeterol—Muscle spasms—Citalopram—alcohol dependence	0.000543	0.00139	CcSEcCtD
Salmeterol—CYP2C8—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.00054	0.00389	CbGpPWpGaD
Salmeterol—CYP3A7—Biological oxidations—MAOB—alcohol dependence	0.000538	0.00388	CbGpPWpGaD
Salmeterol—Hypersensitivity—Naltrexone—alcohol dependence	0.000536	0.00137	CcSEcCtD
Salmeterol—CYP3A5—Biological oxidations—ADH7—alcohol dependence	0.000536	0.00386	CbGpPWpGaD
Salmeterol—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000532	0.00384	CbGpPWpGaD
Salmeterol—Tremor—Citalopram—alcohol dependence	0.000529	0.00135	CcSEcCtD
Salmeterol—Diarrhoea—Acamprosate—alcohol dependence	0.000526	0.00135	CcSEcCtD
Salmeterol—CYP2C8—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000525	0.00379	CbGpPWpGaD
Salmeterol—Ill-defined disorder—Citalopram—alcohol dependence	0.000524	0.00134	CcSEcCtD
Salmeterol—Asthenia—Naltrexone—alcohol dependence	0.000522	0.00133	CcSEcCtD
Salmeterol—CYP3A4—Tryptophan metabolism—MAOB—alcohol dependence	0.00052	0.00375	CbGpPWpGaD
Salmeterol—Agitation—Citalopram—alcohol dependence	0.000519	0.00133	CcSEcCtD
Salmeterol—Angioedema—Citalopram—alcohol dependence	0.000516	0.00132	CcSEcCtD
Salmeterol—CYP3A5—Biological oxidations—GGT2—alcohol dependence	0.000514	0.0037	CbGpPWpGaD
Salmeterol—Malaise—Citalopram—alcohol dependence	0.000509	0.0013	CcSEcCtD
Salmeterol—Dizziness—Acamprosate—alcohol dependence	0.000508	0.0013	CcSEcCtD
Salmeterol—Palpitations—Citalopram—alcohol dependence	0.000499	0.00128	CcSEcCtD
Salmeterol—CYP3A5—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000498	0.00359	CbGpPWpGaD
Salmeterol—Diarrhoea—Naltrexone—alcohol dependence	0.000498	0.00127	CcSEcCtD
Salmeterol—Cough—Citalopram—alcohol dependence	0.000493	0.00126	CcSEcCtD
Salmeterol—Vomiting—Acamprosate—alcohol dependence	0.000489	0.00125	CcSEcCtD
Salmeterol—Hypertension—Citalopram—alcohol dependence	0.000488	0.00125	CcSEcCtD
Salmeterol—Rash—Acamprosate—alcohol dependence	0.000485	0.00124	CcSEcCtD
Salmeterol—Dermatitis—Acamprosate—alcohol dependence	0.000484	0.00124	CcSEcCtD
Salmeterol—Headache—Acamprosate—alcohol dependence	0.000482	0.00123	CcSEcCtD
Salmeterol—Dizziness—Naltrexone—alcohol dependence	0.000481	0.00123	CcSEcCtD
Salmeterol—Arthralgia—Citalopram—alcohol dependence	0.000481	0.00123	CcSEcCtD
Salmeterol—Chest pain—Citalopram—alcohol dependence	0.000481	0.00123	CcSEcCtD
Salmeterol—Myalgia—Citalopram—alcohol dependence	0.000481	0.00123	CcSEcCtD
Salmeterol—Anxiety—Citalopram—alcohol dependence	0.000479	0.00123	CcSEcCtD
Salmeterol—Unspecified disorder of skin and subcutaneous tissue—Citalopram—alcohol dependence	0.000477	0.00122	CcSEcCtD
Salmeterol—Discomfort—Citalopram—alcohol dependence	0.000475	0.00121	CcSEcCtD
Salmeterol—Dry mouth—Citalopram—alcohol dependence	0.00047	0.0012	CcSEcCtD
Salmeterol—CYP3A5—Biological oxidations—ADH1B—alcohol dependence	0.00047	0.00339	CbGpPWpGaD
Salmeterol—CYP3A4—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.000469	0.00338	CbGpPWpGaD
Salmeterol—ADRB2—GPCRs, Class A Rhodopsin-like—OPRD1—alcohol dependence	0.000468	0.00337	CbGpPWpGaD
Salmeterol—ADRB2—G alpha (s) signalling events—HTR7—alcohol dependence	0.000467	0.00337	CbGpPWpGaD
Salmeterol—CYP2C8—Biological oxidations—ADH7—alcohol dependence	0.000464	0.00334	CbGpPWpGaD
Salmeterol—Vomiting—Naltrexone—alcohol dependence	0.000462	0.00118	CcSEcCtD
Salmeterol—Anaphylactic shock—Citalopram—alcohol dependence	0.000461	0.00118	CcSEcCtD
Salmeterol—Oedema—Citalopram—alcohol dependence	0.000461	0.00118	CcSEcCtD
Salmeterol—Rash—Naltrexone—alcohol dependence	0.000459	0.00117	CcSEcCtD
Salmeterol—Dermatitis—Naltrexone—alcohol dependence	0.000458	0.00117	CcSEcCtD
Salmeterol—Infection—Citalopram—alcohol dependence	0.000458	0.00117	CcSEcCtD
Salmeterol—CYP3A7—Biological oxidations—ALDH2—alcohol dependence	0.000458	0.0033	CbGpPWpGaD
Salmeterol—Nausea—Acamprosate—alcohol dependence	0.000457	0.00117	CcSEcCtD
Salmeterol—Headache—Naltrexone—alcohol dependence	0.000456	0.00117	CcSEcCtD
Salmeterol—CYP3A7—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000455	0.00328	CbGpPWpGaD
Salmeterol—ADRB2—GPCR ligand binding—OPRK1—alcohol dependence	0.000454	0.00327	CbGpPWpGaD
Salmeterol—Nervous system disorder—Citalopram—alcohol dependence	0.000452	0.00116	CcSEcCtD
Salmeterol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—alcohol dependence	0.00045	0.00324	CbGpPWpGaD
Salmeterol—Tachycardia—Citalopram—alcohol dependence	0.00045	0.00115	CcSEcCtD
Salmeterol—Skin disorder—Citalopram—alcohol dependence	0.000448	0.00115	CcSEcCtD
Salmeterol—CYP2C8—Biological oxidations—GGT2—alcohol dependence	0.000445	0.00321	CbGpPWpGaD
Salmeterol—CYP3A4—Tryptophan metabolism—ALDH2—alcohol dependence	0.000442	0.00319	CbGpPWpGaD
Salmeterol—Nausea—Naltrexone—alcohol dependence	0.000432	0.00111	CcSEcCtD
Salmeterol—CYP2C8—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000431	0.00311	CbGpPWpGaD
Salmeterol—Musculoskeletal discomfort—Citalopram—alcohol dependence	0.00042	0.00107	CcSEcCtD
Salmeterol—ADRB2—GPCRs, Other—HTR2A—alcohol dependence	0.000419	0.00302	CbGpPWpGaD
Salmeterol—Insomnia—Citalopram—alcohol dependence	0.000417	0.00107	CcSEcCtD
Salmeterol—CYP3A4—Biological oxidations—ADH6—alcohol dependence	0.000416	0.003	CbGpPWpGaD
Salmeterol—Paraesthesia—Citalopram—alcohol dependence	0.000414	0.00106	CcSEcCtD
Salmeterol—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.000411	0.00296	CbGpPWpGaD
Salmeterol—Dyspnoea—Citalopram—alcohol dependence	0.000411	0.00105	CcSEcCtD
Salmeterol—CYP3A5—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.00041	0.00295	CbGpPWpGaD
Salmeterol—CYP2C8—Biological oxidations—ADH1B—alcohol dependence	0.000407	0.00293	CbGpPWpGaD
Salmeterol—Dyspepsia—Citalopram—alcohol dependence	0.000406	0.00104	CcSEcCtD
Salmeterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—OPRD1—alcohol dependence	0.000401	0.00289	CbGpPWpGaD
Salmeterol—Fatigue—Citalopram—alcohol dependence	0.000397	0.00102	CcSEcCtD
Salmeterol—Pain—Citalopram—alcohol dependence	0.000394	0.00101	CcSEcCtD
Salmeterol—Constipation—Citalopram—alcohol dependence	0.000394	0.00101	CcSEcCtD
Salmeterol—ADRB2—G alpha (s) signalling events—AVP—alcohol dependence	0.000393	0.00284	CbGpPWpGaD
Salmeterol—ADRB2—GPCRs, Class A Rhodopsin-like—CHRM2—alcohol dependence	0.000392	0.00282	CbGpPWpGaD
Salmeterol—CYP3A5—Biological oxidations—MAOB—alcohol dependence	0.000389	0.00281	CbGpPWpGaD
Salmeterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—PDYN—alcohol dependence	0.000384	0.00277	CbGpPWpGaD
Salmeterol—Feeling abnormal—Citalopram—alcohol dependence	0.00038	0.000971	CcSEcCtD
Salmeterol—Gastrointestinal pain—Citalopram—alcohol dependence	0.000377	0.000964	CcSEcCtD
Salmeterol—CYP3A7—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000369	0.00266	CbGpPWpGaD
Salmeterol—Urticaria—Citalopram—alcohol dependence	0.000366	0.000937	CcSEcCtD
Salmeterol—CYP3A7—Biological oxidations—CYP2E1—alcohol dependence	0.000366	0.00264	CbGpPWpGaD
Salmeterol—Body temperature increased—Citalopram—alcohol dependence	0.000364	0.000932	CcSEcCtD
Salmeterol—Abdominal pain—Citalopram—alcohol dependence	0.000364	0.000932	CcSEcCtD
Salmeterol—CYP3A7—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000361	0.0026	CbGpPWpGaD
Salmeterol—ADRB2—GPCRs, Class A Rhodopsin-like—OPRM1—alcohol dependence	0.00036	0.00259	CbGpPWpGaD
Salmeterol—CYP2C8—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000355	0.00256	CbGpPWpGaD
Salmeterol—CYP3A4—Tryptophan metabolism—CYP2E1—alcohol dependence	0.000353	0.00255	CbGpPWpGaD
Salmeterol—CYP3A4—Biological oxidations—ADH1A—alcohol dependence	0.000344	0.00248	CbGpPWpGaD
Salmeterol—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000341	0.00246	CbGpPWpGaD
Salmeterol—Hypersensitivity—Citalopram—alcohol dependence	0.00034	0.000869	CcSEcCtD
Salmeterol—CYP2C8—Biological oxidations—MAOB—alcohol dependence	0.000337	0.00243	CbGpPWpGaD
Salmeterol—CYP3A7—Biological oxidations—GGT1—alcohol dependence	0.000336	0.00242	CbGpPWpGaD
Salmeterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CHRM2—alcohol dependence	0.000336	0.00242	CbGpPWpGaD
Salmeterol—CYP3A5—Biological oxidations—ALDH2—alcohol dependence	0.000331	0.00239	CbGpPWpGaD
Salmeterol—Asthenia—Citalopram—alcohol dependence	0.000331	0.000846	CcSEcCtD
Salmeterol—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000329	0.00237	CbGpPWpGaD
Salmeterol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR1B—alcohol dependence	0.000319	0.0023	CbGpPWpGaD
Salmeterol—Diarrhoea—Citalopram—alcohol dependence	0.000315	0.000807	CcSEcCtD
Salmeterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—OPRM1—alcohol dependence	0.000308	0.00222	CbGpPWpGaD
Salmeterol—ADRB2—GPCR ligand binding—OPRD1—alcohol dependence	0.000305	0.0022	CbGpPWpGaD
Salmeterol—Dizziness—Citalopram—alcohol dependence	0.000305	0.00078	CcSEcCtD
Salmeterol—CYP3A7—Biological oxidations—MAOA—alcohol dependence	0.000301	0.00217	CbGpPWpGaD
Salmeterol—Vomiting—Citalopram—alcohol dependence	0.000293	0.00075	CcSEcCtD
Salmeterol—CYP3A4—Biological oxidations—ADH4—alcohol dependence	0.000293	0.00211	CbGpPWpGaD
Salmeterol—ADRB2—GPCR ligand binding—PDYN—alcohol dependence	0.000292	0.00211	CbGpPWpGaD
Salmeterol—Rash—Citalopram—alcohol dependence	0.000291	0.000743	CcSEcCtD
Salmeterol—Dermatitis—Citalopram—alcohol dependence	0.00029	0.000743	CcSEcCtD
Salmeterol—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.00029	0.00209	CbGpPWpGaD
Salmeterol—Headache—Citalopram—alcohol dependence	0.000289	0.000739	CcSEcCtD
Salmeterol—CYP2C8—Biological oxidations—ALDH2—alcohol dependence	0.000287	0.00207	CbGpPWpGaD
Salmeterol—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000286	0.00206	CbGpPWpGaD
Salmeterol—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000285	0.00205	CbGpPWpGaD
Salmeterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—NPY—alcohol dependence	0.000284	0.00204	CbGpPWpGaD
Salmeterol—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000282	0.00203	CbGpPWpGaD
Salmeterol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD4—alcohol dependence	0.000279	0.00201	CbGpPWpGaD
Salmeterol—Nausea—Citalopram—alcohol dependence	0.000274	0.0007	CcSEcCtD
Salmeterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR1B—alcohol dependence	0.000274	0.00197	CbGpPWpGaD
Salmeterol—ADRB2—GPCR ligand binding—CRHR1—alcohol dependence	0.000272	0.00196	CbGpPWpGaD
Salmeterol—CYP3A5—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000267	0.00192	CbGpPWpGaD
Salmeterol—ADRB2—GPCRs, Class A Rhodopsin-like—CNR1—alcohol dependence	0.000267	0.00192	CbGpPWpGaD
Salmeterol—CYP3A5—Biological oxidations—CYP2E1—alcohol dependence	0.000265	0.00191	CbGpPWpGaD
Salmeterol—ADRB2—G alpha (s) signalling events—POMC—alcohol dependence	0.000261	0.00188	CbGpPWpGaD
Salmeterol—CYP3A5—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000261	0.00188	CbGpPWpGaD
Salmeterol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR7—alcohol dependence	0.00026	0.00187	CbGpPWpGaD
Salmeterol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD2—alcohol dependence	0.00026	0.00187	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—OPRK1—alcohol dependence	0.000256	0.00185	CbGpPWpGaD
Salmeterol—ADRB2—GPCR ligand binding—CHRM2—alcohol dependence	0.000256	0.00184	CbGpPWpGaD
Salmeterol—CYP3A4—Biological oxidations—ADH7—alcohol dependence	0.000249	0.0018	CbGpPWpGaD
Salmeterol—CYP3A5—Biological oxidations—GGT1—alcohol dependence	0.000243	0.00175	CbGpPWpGaD
Salmeterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD4—alcohol dependence	0.000239	0.00172	CbGpPWpGaD
Salmeterol—CYP3A4—Biological oxidations—GGT2—alcohol dependence	0.000239	0.00172	CbGpPWpGaD
Salmeterol—ADRB2—GPCR ligand binding—OPRM1—alcohol dependence	0.000235	0.00169	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—OPRK1—alcohol dependence	0.000233	0.00168	CbGpPWpGaD
Salmeterol—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000232	0.00167	CbGpPWpGaD
Salmeterol—CYP2C8—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000231	0.00167	CbGpPWpGaD
Salmeterol—CYP2C8—Biological oxidations—CYP2E1—alcohol dependence	0.000229	0.00165	CbGpPWpGaD
Salmeterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CNR1—alcohol dependence	0.000228	0.00165	CbGpPWpGaD
Salmeterol—CYP2C8—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000226	0.00163	CbGpPWpGaD
Salmeterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR7—alcohol dependence	0.000223	0.00161	CbGpPWpGaD
Salmeterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD2—alcohol dependence	0.000223	0.00161	CbGpPWpGaD
Salmeterol—CYP3A4—Biological oxidations—ADH1B—alcohol dependence	0.000218	0.00157	CbGpPWpGaD
Salmeterol—CYP3A5—Biological oxidations—MAOA—alcohol dependence	0.000218	0.00157	CbGpPWpGaD
Salmeterol—ADRB2—GPCR ligand binding—NPY—alcohol dependence	0.000216	0.00156	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—ADH6—alcohol dependence	0.000212	0.00152	CbGpPWpGaD
Salmeterol—CYP2C8—Biological oxidations—GGT1—alcohol dependence	0.00021	0.00152	CbGpPWpGaD
Salmeterol—ADRB2—GPCR ligand binding—CRH—alcohol dependence	0.000208	0.0015	CbGpPWpGaD
Salmeterol—ADRB2—GPCR ligand binding—HTR1B—alcohol dependence	0.000208	0.0015	CbGpPWpGaD
Salmeterol—CYP3A7—Biological oxidations—POMC—alcohol dependence	0.000196	0.00141	CbGpPWpGaD
Salmeterol—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000191	0.00137	CbGpPWpGaD
Salmeterol—CYP2C8—Biological oxidations—MAOA—alcohol dependence	0.000189	0.00136	CbGpPWpGaD
Salmeterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—AVP—alcohol dependence	0.000188	0.00135	CbGpPWpGaD
Salmeterol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—alcohol dependence	0.000182	0.00131	CbGpPWpGaD
Salmeterol—ADRB2—GPCR ligand binding—DRD4—alcohol dependence	0.000182	0.00131	CbGpPWpGaD
Salmeterol—CYP3A4—Biological oxidations—MAOB—alcohol dependence	0.000181	0.0013	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—ADH1A—alcohol dependence	0.000175	0.00126	CbGpPWpGaD
Salmeterol—ADRB2—GPCR ligand binding—CNR1—alcohol dependence	0.000174	0.00125	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—OPRD1—alcohol dependence	0.000172	0.00124	CbGpPWpGaD
Salmeterol—ADRB2—GPCR ligand binding—HTR7—alcohol dependence	0.00017	0.00122	CbGpPWpGaD
Salmeterol—ADRB2—GPCR ligand binding—DRD2—alcohol dependence	0.00017	0.00122	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—PDYN—alcohol dependence	0.000165	0.00119	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—OPRD1—alcohol dependence	0.000157	0.00113	CbGpPWpGaD
Salmeterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—alcohol dependence	0.000156	0.00113	CbGpPWpGaD
Salmeterol—CYP3A4—Biological oxidations—ALDH2—alcohol dependence	0.000154	0.00111	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—CRHR1—alcohol dependence	0.000154	0.00111	CbGpPWpGaD
Salmeterol—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000153	0.0011	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—ADH6—alcohol dependence	0.000153	0.0011	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—PDYN—alcohol dependence	0.00015	0.00108	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—ADH4—alcohol dependence	0.000149	0.00107	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—CHRM2—alcohol dependence	0.000144	0.00104	CbGpPWpGaD
Salmeterol—ADRB2—GPCR ligand binding—AVP—alcohol dependence	0.000143	0.00103	CbGpPWpGaD
Salmeterol—CYP3A5—Biological oxidations—POMC—alcohol dependence	0.000142	0.00102	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—CRHR1—alcohol dependence	0.00014	0.00101	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—OPRK1—alcohol dependence	0.000138	0.000992	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—OPRM1—alcohol dependence	0.000133	0.000956	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—ADH6—alcohol dependence	0.000132	0.000955	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—CHRM2—alcohol dependence	0.000131	0.000946	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—ADH7—alcohol dependence	0.000127	0.000914	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—ADH1A—alcohol dependence	0.000127	0.000913	CbGpPWpGaD
Salmeterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—POMC—alcohol dependence	0.000125	0.000898	CbGpPWpGaD
Salmeterol—CYP3A4—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000124	0.000894	CbGpPWpGaD
Salmeterol—CYP3A4—Biological oxidations—CYP2E1—alcohol dependence	0.000123	0.000887	CbGpPWpGaD
Salmeterol—CYP2C8—Biological oxidations—POMC—alcohol dependence	0.000123	0.000885	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—NPY—alcohol dependence	0.000122	0.00088	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—GGT2—alcohol dependence	0.000121	0.000876	CbGpPWpGaD
Salmeterol—CYP3A4—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000121	0.000874	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—OPRM1—alcohol dependence	0.00012	0.000868	CbGpPWpGaD
Salmeterol—ADRB2—GPCR ligand binding—HTR2A—alcohol dependence	0.000119	0.000857	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—CRH—alcohol dependence	0.000118	0.000849	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—HTR1B—alcohol dependence	0.000118	0.000849	CbGpPWpGaD
Salmeterol—CYP3A4—Biological oxidations—GGT1—alcohol dependence	0.000113	0.000814	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—ADH1B—alcohol dependence	0.000111	0.000801	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—NPY—alcohol dependence	0.000111	0.000799	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—ADH1A—alcohol dependence	0.00011	0.000791	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—ADH4—alcohol dependence	0.000108	0.000777	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—HTR1B—alcohol dependence	0.000107	0.000771	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—CRH—alcohol dependence	0.000107	0.000771	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—DRD4—alcohol dependence	0.000103	0.000742	CbGpPWpGaD
Salmeterol—CYP3A4—Biological oxidations—MAOA—alcohol dependence	0.000101	0.000729	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—CNR1—alcohol dependence	9.83e-05	0.000709	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—HTR7—alcohol dependence	9.59e-05	0.000691	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—DRD2—alcohol dependence	9.59e-05	0.000691	CbGpPWpGaD
Salmeterol—ADRB2—GPCR ligand binding—POMC—alcohol dependence	9.49e-05	0.000684	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—DRD4—alcohol dependence	9.35e-05	0.000674	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—ADH4—alcohol dependence	9.33e-05	0.000673	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—OPRD1—alcohol dependence	9.25e-05	0.000667	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—MAOB—alcohol dependence	9.21e-05	0.000664	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—ADH7—alcohol dependence	9.16e-05	0.00066	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—CNR1—alcohol dependence	8.93e-05	0.000643	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—PDYN—alcohol dependence	8.87e-05	0.000639	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—GGT2—alcohol dependence	8.78e-05	0.000633	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—HTR7—alcohol dependence	8.71e-05	0.000628	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—DRD2—alcohol dependence	8.71e-05	0.000628	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—CRHR1—alcohol dependence	8.24e-05	0.000594	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—WASF2—alcohol dependence	8.24e-05	0.000594	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	8.08e-05	0.000582	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—AVP—alcohol dependence	8.07e-05	0.000582	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—ADH1B—alcohol dependence	8.03e-05	0.000579	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—ADH7—alcohol dependence	7.93e-05	0.000572	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—WASF1—alcohol dependence	7.9e-05	0.00057	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—ALDH2—alcohol dependence	7.83e-05	0.000564	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—CHRM2—alcohol dependence	7.75e-05	0.000559	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—GGT2—alcohol dependence	7.61e-05	0.000548	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—AVP—alcohol dependence	7.33e-05	0.000528	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—OPRM1—alcohol dependence	7.12e-05	0.000513	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—ADH6—alcohol dependence	7.11e-05	0.000512	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—ADH1B—alcohol dependence	6.96e-05	0.000502	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—HTR2A—alcohol dependence	6.72e-05	0.000484	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—GOT2—alcohol dependence	6.66e-05	0.00048	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—MAOB—alcohol dependence	6.66e-05	0.00048	CbGpPWpGaD
Salmeterol—CYP3A4—Biological oxidations—POMC—alcohol dependence	6.59e-05	0.000475	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—NPY—alcohol dependence	6.55e-05	0.000472	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—HTR1B—alcohol dependence	6.32e-05	0.000455	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—CRH—alcohol dependence	6.32e-05	0.000455	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—CYP2E1—alcohol dependence	6.26e-05	0.000451	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—HTR2A—alcohol dependence	6.1e-05	0.00044	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—ADH1A—alcohol dependence	5.89e-05	0.000425	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—MAOB—alcohol dependence	5.76e-05	0.000416	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—GGT1—alcohol dependence	5.75e-05	0.000414	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—GOT1—alcohol dependence	5.75e-05	0.000414	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—ALDH2—alcohol dependence	5.66e-05	0.000408	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—DRD4—alcohol dependence	5.52e-05	0.000398	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—POMC—alcohol dependence	5.36e-05	0.000387	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—CNR1—alcohol dependence	5.27e-05	0.00038	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—MAOA—alcohol dependence	5.15e-05	0.000371	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—DRD2—alcohol dependence	5.14e-05	0.000371	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—HTR7—alcohol dependence	5.14e-05	0.000371	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—ADH4—alcohol dependence	5.01e-05	0.000361	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—ALDH2—alcohol dependence	4.9e-05	0.000353	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—POMC—alcohol dependence	4.87e-05	0.000351	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—GOT2—alcohol dependence	4.81e-05	0.000347	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	4.71e-05	0.00034	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—CYP2E1—alcohol dependence	4.52e-05	0.000326	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—AVP—alcohol dependence	4.33e-05	0.000312	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—ADH7—alcohol dependence	4.26e-05	0.000307	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—GOT2—alcohol dependence	4.17e-05	0.0003	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—GGT1—alcohol dependence	4.15e-05	0.000299	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—GOT1—alcohol dependence	4.15e-05	0.000299	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—GGT2—alcohol dependence	4.08e-05	0.000294	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—CYP2E1—alcohol dependence	3.92e-05	0.000282	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—ADH1B—alcohol dependence	3.73e-05	0.000269	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—MAOA—alcohol dependence	3.72e-05	0.000268	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—HTR2A—alcohol dependence	3.6e-05	0.00026	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—GGT1—alcohol dependence	3.6e-05	0.000259	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—GOT1—alcohol dependence	3.6e-05	0.000259	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—POMC—alcohol dependence	3.35e-05	0.000242	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—MAOA—alcohol dependence	3.22e-05	0.000232	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	3.13e-05	0.000225	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—MAOB—alcohol dependence	3.09e-05	0.000223	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—POMC—alcohol dependence	2.88e-05	0.000207	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—ALDH2—alcohol dependence	2.63e-05	0.00019	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—POMC—alcohol dependence	2.42e-05	0.000175	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—GOT2—alcohol dependence	2.24e-05	0.000161	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—EP300—alcohol dependence	2.22e-05	0.00016	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—CYP2E1—alcohol dependence	2.1e-05	0.000152	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—POMC—alcohol dependence	2.1e-05	0.000151	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—GOT1—alcohol dependence	1.93e-05	0.000139	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—GGT1—alcohol dependence	1.93e-05	0.000139	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—EP300—alcohol dependence	1.91e-05	0.000138	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—MAOA—alcohol dependence	1.73e-05	0.000125	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—EP300—alcohol dependence	1.61e-05	0.000116	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—EP300—alcohol dependence	1.39e-05	0.0001	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—POMC—alcohol dependence	1.13e-05	8.12e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—EP300—alcohol dependence	7.47e-06	5.39e-05	CbGpPWpGaD
